Efficacy of probiotic in jaundice

Efficacy of probiotic with phototherapy in compare to phototherapy for treatment of hyperbilirubinemia in fullterm infants

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015112925287N1

Enrollment

Registered

2015-12-18

Start date

2015-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperbilirubinemia. Neonatal jaundice, unspecified

Interventions

Intervention 1: intervention group: in addition to phototherapy neonates will be treated by 5 drops of probiotic (pedilact) once a day till discharge. Intervention 2: control group: during hospitaliza

Treatment - Drugs

intervention group: in addition to phototherapy neonates will be treated by 5 drops of probiotic (pedilact) once a day till discharge.

control group: during hospitalization only receive phototherapy

Eligibility

Sex/Gender

All

Age

2 Days to 7 Days

Inclusion criteria

Inclusion criteria: inclusion criteria: gestational age 37-40 weeks; birth weight 2500-4000 gram; apgar score 8-10 in first and fifth minute. exclusion criteria: sepsis; G6PD deficiency; congenital anomaly; asphyxia; heart disease ;IUGR; contraindication for probiotic therapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Bilirubin. Timepoint: before intervention-every day after intervention. Method of measurement: lab test-milligram per desiliter.	—

Secondary

Measure	Time frame
Weight. Timepoint: before intervention-every day after intervention. Method of measurement: balance-gram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShokufe Ahmadipour

Lorestan University of Medical Sciences

ahmadipour_sh@yahoo.com+98 66 3341 1439

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026